South Korea Newborn Screening Market to 2032
Overview
The South Korea Newborn Screening Market is expected to reach a 117.68 USD Billion by 2032 and is projected to grow at a CAGR of 14.55% from 2025 to 2032.
Revenue, 2024 (USD Billion)
50.54
Forecast, 2032 (USD Billion)
117.68
CAGR, 2024 - 2032
14.55%
Report Coverage
South Korea
South Korea Newborn Screening Market 2018-2032 USD Billion
South Korea Newborn Screening Market , Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 50.54 USD Billion
- Projected Market Size (2032): 117.68 USD Billion
- CAGR (2025-2032): 14.55%
Key Findings of South Korea Newborn Screening Market
- The South Korea Newborn Screening Market was valued at 50.54 USD Billion in 2024.
- The South Korea Newborn Screening Market is likely to grow at a CAGR of 14.55% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital in End User Segment accounted for the largest share of the market with a revenue of 36.28 USD Billion
- The fastest growing segment Tandem Mass Spectrometry in Technology Segment grew Fastest with a CAGR of 15.53% during the forecast period from 2024 to 2032.
South Korea Newborn Screening Market Scope
South Korea Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
South Korea Newborn Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 50.54 USD Billion |
| Market Value in 2032 | 117.68 USD Billion |
| CAGR (2025-2032) | 14.55% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Product Type,Disease Type,Test Type,End User |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 50.54 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 50.54 USD Billion in 2024.
Segments and Scope
-
South Korea Newborn Screening Market to 2032, By Technology
- Tandem Mass Spectrometry is the largest segment in South Korea Newborn Screening Market to 2032 with a revenue of 13.96 USD Billion in the year 2024.
- Tandem Mass Spectrometry is the Fastest growing segment in South Korea Newborn Screening Market to 2032 with a Growth rate of 15.53 % in forecast period 2025-2032.
-
South Korea Newborn Screening Market to 2032, By Product Type
- Instruments is the largest segment in South Korea Newborn Screening Market to 2032 with a revenue of 34.71 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in South Korea Newborn Screening Market to 2032 with a Growth rate of 14.82 % in forecast period 2025-2032.
-
South Korea Newborn Screening Market to 2032, By Disease Type
- Critical Congenital Heart Diseases is the largest segment in South Korea Newborn Screening Market to 2032 with a revenue of 33.10 USD Billion in the year 2024.
- Critical Congenital Heart Diseases is the Fastest growing segment in South Korea Newborn Screening Market to 2032 with a Growth rate of 14.88 % in forecast period 2025-2032.
-
South Korea Newborn Screening Market to 2032, By Test Type
- Dried Blood Spot Test is the largest segment in South Korea Newborn Screening Market to 2032 with a revenue of 22.03 USD Billion in the year 2024.
- Hearing Screen Test is the Fastest growing segment in South Korea Newborn Screening Market to 2032 with a Growth rate of 14.18 % in forecast period 2025-2032.
-
South Korea Newborn Screening Market to 2032, By End User
- Hospital is the largest segment in South Korea Newborn Screening Market to 2032 with a revenue of 36.28 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in South Korea Newborn Screening Market to 2032 with a Growth rate of 14.84 % in forecast period 2025-2032.
South Korea Newborn Screening Market Company Share Analysis
South Korea Newborn Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Newborn Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Disease Type,Test Type,End User.
South Korea Newborn Screening Market was valued at USD 50.54(Revenue in USD Billion) in 2022.
South Korea Newborn Screening Market is projected to grow at a CAGR of 14.55% during the forecast period of 2024 to 2032.
The Hospital segment is expected to dominate the South Korea Newborn Screening Market , holding a largest market share of 36.28 USD Billion in 2024
South Korea Newborn Screening Market Scope
South Korea Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
Frequently Asked Questions
The South Korea Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Disease Type,Test Type,End User.
South Korea Newborn Screening Market was valued at USD 50.54(Revenue in USD Billion) in 2022.
South Korea Newborn Screening Market is projected to grow at a CAGR of 14.55% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Newborn Screening Market for final year is USD 117.68 (USD Billion).
South Korea Newborn Screening Market Company Profiling
Frequently Asked Questions
The South Korea Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Disease Type,Test Type,End User.
South Korea Newborn Screening Market was valued at USD 50.54(Revenue in USD Billion) in 2022.
South Korea Newborn Screening Market is projected to grow at a CAGR of 14.55% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Newborn Screening Market for final year is USD 117.68 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.